Founders Capital Management Caladrius Biosciences, Inc. Transaction History

Founders Capital Management

  • $164 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022
BUY
$0.41 - $0.74 $2,050 - $3,700
5,000 Added 100.0%
10,000 $5,000
Q4 2021

Jan 21, 2022
SELL
$0.83 - $1.22 $8,300 - $12,200
-10,000 Reduced 66.67%
5,000 $4,000
Q2 2021

Jul 15, 2021
BUY
$1.4 - $1.9 $21,000 - $28,500
15,000 New
15,000 $24,000

About CALADRIUS BIOSCIENCES, INC.

CLBS Quotes by TradingView
  • Ticker CLBS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,583,200
  • Market Cap $25.8M
  • Description
  • Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...
More about CLBS
Track This Portfolio

Track Founders Capital Management Portfolio

Follow Founders Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email